Nano Technology based Topical Semisolid Pharmaceutical dosage Forms

International Journal of Pharmacy and Biomedical Engineering

© 2014 by SSRG - IJPBE Journal

Volume 1 Issue 1

Year of Publication : 2014

Authors : B.Yuvan and C.Inniya

10.14445/23942576/IJPBE-V1I1P105

How to Cite?

B.Yuvan and C.Inniya, "Nano Technology based Topical Semisolid Pharmaceutical dosage Forms," SSRG International Journal of Pharmacy and Biomedical Engineering, vol. 1,  no. 1, pp. 13-15, 2014. Crossref, https://doi.org/10.14445/23942576/IJPBE-V1I1P105

Abstract:

The pharmaceutical semisolid dosages are normally present in the form of paste, creams, gels, ointments. Generally, these types of semisolid dosages are used only externally, such as skin allergies, injuries, etc. The bases used in the semisolid pharmaceutical dosage are more sensitive to the skin. The topical semisolid medical dosages are spread smoothly on the body surface. It will react with the cells and injuries for a long time because it adhered to a long time. The main advantages of the semisolid dosage are it does not create side effects. This paper proposes the Nanotechnology-based semisolid dosages, which are more effective than conventional semisolids.

Keywords:

semisolids, cream, ointments, Nano semisolids

References:

[1] The International Pharmacopoeia, World Health Organization 2013, 4th edition
[2] Galderma Wins FDA Approval for Vectical(TM) Ointment: A Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis. FierceBiotech, The biotech industry's daily monitor 2008.
[3] Pinedo G, Zarate AJ, Inostroza G, Meneses X, Falloux E, Molina O, Molina ME, Bellolio F, Zúñiga A: “New treatment for faecal incontinence using the zinc-aluminum ointment: a double-blind, randomized trial”. Colorectal Disease 2012; 14(5):596–598
[4] Süntar I, Akkol EK, Keleş H, Oktem A, Başer KH, Yeşilada E: “A novel wound healing ointment: a formulation of Hypericum perforatum oil and sage and oregano essential oils based on traditional Turkish knowledge”. J Ethnopharmacol 2011; 134(1):89-96.
[5] Carl O, Formulating with microspheres. Technical seminar, April 14, 2008.
[6] Agalloco JP, Carleton FJ; Validation of Pharmaceutical Processes; 3rd edition, 2007: 417-428.
[7] Idson B, Lazarus J; Semisolids. “The Theory and Practice of Industrial Pharmacy”. In Lachman L, Lieberman HA, Kanig JL editors, Varghese Publishing House, Bombay, India, 1991: 534–563.
[8] Block LH; “Medicated Applications. In Gennaro AR editor; Remington: The Science and Practice of Pharmacy”. 19th edition, Mack Publishing Company, Easton, Pennsylvania, 1995: 1590–1597.
[9] Lorenzo CA, Hiratani H, Concheiro A. “Contact lens for drug delivery. Achieving sustained release with novel systems”. Am J Drug Deliv. 2006; 4(3):131–151.
[10] Gibson M. “Ophthalmic Dosage Forms In Gibson M— Pharmaceutical Preformulation and Formulation”. New York: Informa; 2007:459–489.
[11] Ali Y, Lehmussaari K.— “Industrial perspective in ocular drug delivery”. Adv Drug Deliv Rev. 2006; 58: 1258–1268.
[12] Ansel HC — “Introduction to Pharmaceutical Dosage Forms”. 4th ed. Philadelphia: Lea & Febiger; 1985:321–336.